Spain Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Region:Europe
Product Code:GDMEMC0246DB
August 2017
116
About the Report
Spain Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary
GlobalData's new report, "Spain Drug Delivery Devices Market Outlook to 2023", provides key market data on the Spain Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market categories.
Global corporate-level profiles of key companies operating within the Spain Drug Delivery Devices market.
Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
Develop business strategies by identifying the key market categories poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Scope of the Report
Products
Companies
INJEX-Equidyne Systems
Teleflex Inc
B. Braun Melsungen AG
Bioject Medical Technologies Inc
GlaxoSmithKline Plc
Baxter International Inc
Edwards Lifesciences Corp
Antares Pharma Inc
AstraZeneca Plc
Boehringer Ingelheim GmbH
Fresenius Kabi AG
Pfizer Inc
Merck & Co Inc
Becton Dickinson and Co
C. R. Bard Inc
Smiths Medical
Terumo Corp
Teva Pharmaceutical Industries Ltd
Medtronic Plc
Hospira Inc
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, Spain 11
3.1 Drug Delivery Devices Market, Spain, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, Spain, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, Spain, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, Spain, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, Spain, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, Spain, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, Spain, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, Spain, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, Spain, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, Spain, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, Spain 28
4.1 Central Venous Catheters Market, Spain, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, Spain, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, Spain, Revenue ($m), by Segment, 2009-2016 30
4.4 Central Venous Catheters Market, Spain, Revenue ($m) by Segment, 2016-2023 32
4.5 Central Venous Catheters Market, Spain, Volume (Units) by Segment, 2009-2016 34
4.6 Central Venous Catheters Market, Spain, Volume (Units) by Segment, 2016-2023 36
4.7 Central Venous Catheters Market, Spain, Distribution Share, Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, Spain, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, Spain 41
5.1 Infusion Systems Market, Spain, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, Spain, Segment Contribution (%), 2016 42
5.3 Infusion Systems Market, Spain, Revenue ($m), 2009-2016 43
5.4 Infusion Systems Market, Spain, Revenue ($m), 2016-2023 45
5.4.1 Ambulatory Infusion Pumps Market, Spain, Revenue ($m), by Segment, 2009-2016 47
5.4.2 Syringe Pumps Market, Spain, Revenue ($m), by Segment, 2009-2016 49
5.4.3 Ambulatory Infusion Pumps Market, Spain, Revenue ($m), by Segment, 2016-2023 51
5.4.4 Syringe Pumps Market, Spain, Revenue ($m), by Segment, 2016-2023 53
5.5 Infusion Systems Market, Spain, Volume (Units), 2009-2016 55
5.6 Infusion Systems Market, Spain, Volume (Units), 2016-2023 57
5.6.1 Ambulatory Infusion Pumps Market, Spain, Volume (Units), by Segment, 2009-2016 59
5.6.2 Syringe Pumps Market, Spain, Volume (Units), by Segment, 2009-2016 61
5.6.3 Ambulatory Infusion Pumps Market, Spain, Volume (Units), by Segment, 2016-2023 63
5.6.4 Syringe Pumps Market, Spain, Volume (Units), by Segment, 2016-2023 65
5.7 Infusion Systems Market, Spain, Distribution Share by Revenue ($m), 2015-2016 67
5.8 Infusion Systems Market, Spain, Company Share by Revenue ($m), 2016 68
6 Metered Dose Inhaler Devices Market, Spain 70
6.1 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2009-2016 70
6.2 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2016-2023 71
6.3 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2009-2016 72
6.4 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2016-2023 73
6.5 Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), 2015-2016 74
6.6 Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), 2016 75
7 Needle Free Injections Market, Spain 77
7.1 Needle Free Injections Market, Spain, Revenue ($m), 2009-2016 77
7.2 Needle Free Injections Market, Spain, Revenue ($m), 2016-2023 78
7.3 Needle Free Injections Market, Spain, Volume (Units), 2009-2016 79
7.4 Needle Free Injections Market, Spain, Volume (Units), 2016-2023 80
7.5 Needle Free Injections Market, Spain, Distribution Share by Revenue ($m), 2015-2016 81
7.6 Needle Free Injections Market, Spain, Company Share by Revenue ($m), 2016 82
8 Overview of Key Companies in Spain, Drug Delivery Devices Market 84
8.1 INJEX-Equidyne Systems 84
8.1.1 Company Overview 84
8.2 Teleflex Inc 84
8.2.1 Company Overview 84
8.3 B. Braun Melsungen AG 84
8.3.1 Company Overview 84
8.4 Bioject Medical Technologies Inc 84
8.4.1 Company Overview 84
8.5 GlaxoSmithKline Plc 85
8.5.1 Company Overview 85
8.6 Baxter International Inc 85
8.6.1 Company Overview 85
8.7 Edwards Lifesciences Corp 85
8.7.1 Company Overview 85
8.8 Antares Pharma Inc 86
8.8.1 Company Overview 86
8.9 AstraZeneca Plc 86
8.9.1 Company Overview 86
8.10 Boehringer Ingelheim GmbH 86
8.10.1 Company Overview 86
8.11 Fresenius Kabi AG 87
8.11.1 Company Overview 87
8.12 Pfizer Inc 87
8.12.1 Company Overview 87
8.13 Merck & Co Inc 87
8.13.1 Company Overview 87
8.14 Becton Dickinson and Co 88
8.14.1 Company Overview 88
8.15 C. R. Bard Inc 88
8.15.1 Company Overview 88
8.16 Smiths Medical 88
8.16.1 Company Overview 88
8.17 Terumo Corp 89
8.17.1 Company Overview 89
8.18 Teva Pharmaceutical Industries Ltd 89
8.18.1 Company Overview 89
8.19 Medtronic Plc 89
8.19.1 Company Overview 89
8.20 Hospira Inc 90
8.20.1 Company Overview 90
9 Drug Delivery Devices Market Pipeline Products 91
10 Financial Deals Landscape 96
10.1 Asset Transactions 96
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 96
10.2 Partnerships 98
10.2.1 Alimera Sciences Enters into Licensing Agreement with pSivida 98
10.2.2 Bluegrass Vascular Enters into Partnership with Merit Medical 99
10.2.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 100
10.2.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 101
10.2.5 Propeller Health Enters into Agreement with Novartis Pharma 103
10.2.6 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 104
10.2.7 Pfizer Terminates its Licensing Agreement with pSivida 105
10.2.8 Clinigen Group Enters into Distribution Agreement with BioQ Pharma 106
10.2.9 Bayer Enters into Licensing Agreement with DelSiTech 107
10.2.10 BioCorRx Enters into Licensing Agreement with Therakine 108
11 Recent Developments 109
11.1 Corporate Communications 109
11.1.1 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 109
11.2 Financial Announcements 110
11.2.1 Oct 03, 2016: International Marketing of CytoSorb Commences at European Association for Cardio-Thoracic Surgery Conference 110
12 Appendix 112
12.1 Research Methodology 113
12.1.1 Coverage 113
12.1.2 Secondary Research 113
12.1.3 Primary Research 114
12.1.4 Company Share Analysis 114
12.1.5 Distribution Share Analysis 114
12.1.6 Benchmarking 115
12.2 GlobalData Consulting 115
12.3 Contact Us 116
12.4 Disclaimer 116
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.